Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01708694 · ClinicalTrials.gov registry record · NA
Role of Slowly Digesible Starch on Diabetes Risk Factors
A NA study, sponsored by Pennington Biomedical Research Center.
- Completed
- Registry status
- NA
- Development phase
- 65
- Enrollment target
NCT01708694: Completed NA study, sponsored by Pennington Biomedical Research Center.
NCT01708694 is a NA study that has completed, run by Pennington Biomedical Research Center. The registered enrollment target is 65 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01708694, a NA study, has completed, sponsored by Pennington Biomedical Research Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 65 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the effect of a slowly digesting starch on gut bacteria, sugar and fat metabolism, hunger hormones, and body fat in people with pre-diabetes.
Primary Outcome
Insulin sensitivity and secretion will be assessed via a Frequently Sampled Intravenous Glucose Tolerance Test (FSIGTT).
Interventions
- DIETARY_SUPPLEMENT Amylose
- DIETARY_SUPPLEMENT Amylopectin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2012-08 |
| Est. Completion | 2016-06 |
| Phase | NA |
What the finished NCT01708694 record still lists
NCT01708694 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 65 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 2 interventions - of which Amylose is the first listed.
NCT01708694 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01708694 about?
NCT01708694 is a clinical study titled "Role of Slowly Digesible Starch on Diabetes Risk Factors". The purpose of this study is to determine the effect of a slowly digesting starch on gut bacteria, sugar and fat metabolism, hunger hormones, and body fat in people with pre-diabetes.
What is the current status of trial NCT01708694?
This trial is currently completed. It is a NA study. The enrollment target is 65 participants. The study started on 2012-08. Estimated completion is 2016-06.
What interventions are being tested in trial NCT01708694?
The interventions under investigation include: Amylose (DIETARY_SUPPLEMENT), Amylopectin (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01708694?
This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01708694's enrollment target sits among peer trials
65 1144th of 2000 higher than 854 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03366116 · 65 participants · Phase 1
5-aza-4'-Thio-2'-Deoxycytidine (Aza-TdC) in People With Advanced Solid Tumors
- NCT03603730 · 65 participants · NA
Vagal Nerve Stimulation for Functional Dyspepsia and Gastroparesis
- NCT03796559 · 65 participants · NA
Magseed Enabled Long-Term Localization of Axillary Lymph Nodes
- NCT03993106 · 65 participants · Phase 2
A Study of sEphB4-HSA in Kaposi Sarcoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia